Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.

Bradt V, Malafa S, von Braun A, Jarmer J, Tsouchnikas G, Medits I, Wanke K, Karrer U, Stiasny K, Heinz FX.

NPJ Vaccines. 2019 Sep 6;4:38. doi: 10.1038/s41541-019-0133-5. eCollection 2019.

2.

Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti-Pathogen Immunity.

Jayachandran R, Gumienny A, Bolinger B, Ruehl S, Lang MJ, Fucile G, Mazumder S, Tchang V, Woischnig AK, Stiess M, Kunz G, Claudi B, Schmaler M, Siegmund K, Li J, Dertschnig S, Holländer G, Medina E, Karrer U, Moshous D, Bumann D, Khanna N, Rossi SW, Pieters J.

Immunity. 2019 Jan 15;50(1):152-165.e8. doi: 10.1016/j.immuni.2018.12.011. Epub 2019 Jan 2.

PMID:
30611611
3.

Population Genomics of Francisella tularensis subsp. holarctica and its Implication on the Eco-Epidemiology of Tularemia in Switzerland.

Wittwer M, Altpeter E, Pilo P, Gygli SM, Beuret C, Foucault F, Ackermann-Gäumann R, Karrer U, Jacob D, Grunow R, Schürch N.

Front Cell Infect Microbiol. 2018 Mar 22;8:89. doi: 10.3389/fcimb.2018.00089. eCollection 2018.

4.

Role for coronin 1 in mouse NK cell function.

Tchang VSY, Stiess M, Siegmund K, Karrer U, Pieters J.

Immunobiology. 2017 Feb;222(2):291-300. doi: 10.1016/j.imbio.2016.09.011. Epub 2016 Sep 20.

PMID:
27717523
5.

Reduced naïve CD8(+) T-cell priming efficacy in elderly adults.

Briceño O, Lissina A, Wanke K, Afonso G, von Braun A, Ragon K, Miquel T, Gostick E, Papagno L, Stiasny K, Price DA, Mallone R, Sauce D, Karrer U, Appay V.

Aging Cell. 2016 Feb;15(1):14-21. doi: 10.1111/acel.12384. Epub 2015 Oct 15.

6.

Vertebral discitis after laparoscopic resection rectopexy: a rare differential diagnosis.

Probst P, Knoll SN, Breitenstein S, Karrer U.

J Surg Case Rep. 2014 Aug 1;2014(8). pii: rju075. doi: 10.1093/jscr/rju075.

7.

Diverging role for coronin 1 in antiviral CD4+ and CD8+ T cell responses.

Tchang VS, Mekker A, Siegmund K, Karrer U, Pieters J.

Mol Immunol. 2013 Dec;56(4):683-92. doi: 10.1016/j.molimm.2013.05.003. Epub 2013 Aug 8.

PMID:
23933558
8.

Dissection of antibody specificities induced by yellow fever vaccination.

Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, Roggendorf M, Roggendorf H, Allwinn R, Heinz FX.

PLoS Pathog. 2013;9(6):e1003458. doi: 10.1371/journal.ppat.1003458. Epub 2013 Jun 20.

9.

Differential diagnosis of Lemierre's syndrome in a patient with acute paresis of the abducens and oculomotor nerves.

Gutzeit A, Roos JE, Portocarrero-Fäh B, Reischauer C, Claas L, Gassmann K, Hergan K, Kos S, Rodic B, Winkler K, Karrer U, Sartoretti-Schefer S.

Korean J Ophthalmol. 2013 Jun;27(3):219-23. doi: 10.3341/kjo.2013.27.3.219. Epub 2013 May 23.

10.

Impact of antigen specificity on CD4+ T cell activation in chronic HIV-1 infection.

Smith MZ, Bastidas S, Karrer U, Oxenius A.

BMC Infect Dis. 2013 Feb 25;13:100. doi: 10.1186/1471-2334-13-100.

11.

[Secondary hypogammaglobulinemia with recurrent opportunistic pulmonary infection].

Portocarrero B, Ballmer P, Hess T, Karrer U.

Ther Umsch. 2012 Dec;69(12):687-91. doi: 10.1024/0040-5930/a000350. German.

PMID:
23188780
12.

Close geographic association of human neoehrlichiosis and tick populations carrying "Candidatus Neoehrlichia mikurensis" in eastern Switzerland.

Maurer FP, Keller PM, Beuret C, Joha C, Achermann Y, Gubler J, Bircher D, Karrer U, Fehr J, Zimmerli L, Bloemberg GV.

J Clin Microbiol. 2013 Jan;51(1):169-76. doi: 10.1128/JCM.01955-12. Epub 2012 Oct 31.

13.

Immune senescence: relative contributions of age and cytomegalovirus infection.

Mekker A, Tchang VS, Haeberli L, Oxenius A, Trkola A, Karrer U.

PLoS Pathog. 2012;8(8):e1002850. doi: 10.1371/journal.ppat.1002850. Epub 2012 Aug 16.

14.

Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis.

Stiasny K, Aberle JH, Chmelik V, Karrer U, Holzmann H, Heinz FX.

J Clin Virol. 2012 Jun;54(2):115-20. doi: 10.1016/j.jcv.2012.02.016. Epub 2012 Mar 13.

PMID:
22421535
15.

Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.

Bruessow C, Karrer U, Gubler J, Pless M.

J Clin Oncol. 2012 Apr 20;30(12):e130-2. doi: 10.1200/JCO.2011.39.9634. Epub 2012 Mar 5. No abstract available.

PMID:
22393099
16.

Fatal cytomegalovirus pneumonitis and ileitis in a patient with a cardiac assist device.

Huttner B, Reineke T, Wilhelm MJ, Karrer U.

Am Surg. 2011 Sep;77(9):E182-3. No abstract available.

PMID:
21944601
17.

[Brucellosis as a differential diagnosis of cancer of the testes].

Probst P, Karrer U, Flury-Frei R, John H, Horstmann M.

Urologe A. 2011 Jan;50(1):71-3. doi: 10.1007/s00120-010-2450-1. German.

PMID:
21153396
18.

Cytomegalovirus and immune senescence: culprit or innocent bystander?

Karrer U, Mekker A, Wanke K, Tchang V, Haeberli L.

Exp Gerontol. 2009 Nov;44(11):689-94. doi: 10.1016/j.exger.2009.09.003. Epub 2009 Sep 17. Review.

PMID:
19766181
19.

[Suspected meningitis in adults].

Schihin P, Iliakis D, Karrer U.

Praxis (Bern 1994). 2009 Aug 12;98(16):859-70; quiz 871-2. doi: 10.1024/1661-8157.98.16.859. German. No abstract available.

PMID:
19672823
20.

Disseminated toxoplasmosis in a patient with non-Hodgkin lymphoma.

Herold MA, Kühne R, Vosberg M, Ostheeren-Michaelis S, Vogt P, Karrer U.

Infection. 2009 Dec;37(6):551-4. doi: 10.1007/s15010-009-9007-5.

21.

Hodgkin lymphoma in the Swiss HIV Cohort Study.

Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, Bohlius J, Boffi El Amari E, Karrer U, Jundt G, Bordoni A, Ess S, Franceschi S; Swiss HIV Cohort Study.

Blood. 2009 Jun 4;113(23):5737-42. doi: 10.1182/blood-2009-02-204172. Epub 2009 Mar 31.

PMID:
19336755
22.

Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.

Rehr M, Cahenzli J, Haas A, Price DA, Gostick E, Huber M, Karrer U, Oxenius A.

J Virol. 2008 Apr;82(7):3391-404. doi: 10.1128/JVI.02383-07. Epub 2008 Jan 16.

23.

Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.

Simcock M, Blasko M, Karrer U, Bertisch B, Pless M, Blumer L, Vora S, Robinson JO, Bernasconi E, Terziroli B, Moirandat-Rytz S, Furrer H, Hirschel B, Vernazza P, Sendi P, Rickenbach M, Bucher HC, Battegay M, Koller MT; Swiss HIV Cohort Study.

Antivir Ther. 2007;12(6):931-9.

PMID:
17926647
24.

Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection.

Agnellini P, Wolint P, Rehr M, Cahenzli J, Karrer U, Oxenius A.

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4565-70. Epub 2007 Mar 7.

25.

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial.

Ananworanich J, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Nüesch R, Vernazza P, Bernasconi E, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxrungtham K, Hirschel B; Staccato Study Group; Swiss HIV Cohort Study.

Lancet. 2006 Aug 5;368(9534):459-65.

PMID:
16890832
26.

Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir.

Karrer U, Ledergerber B, Furrer H, Elzi L, Battegay M, Cavassini M, Gayet-Ageron A, Hirschel B, Schmid P, Russotti M, Weber R, Speck RF; Swiss HIV Cohort Study.

AIDS. 2005 Nov 18;19(17):1987-94.

PMID:
16260905
27.

[Primary HIV-1 infection in Zurich: 2002-2004].

Aceto L, Karrer U, Grube Ch, Oberholzer R, Hasse B, Presterl E, Böni J, Kuster H, Trkola A, Weber R, Günthard HF.

Praxis (Bern 1994). 2005 Aug 10;94(32):1199-205. German.

PMID:
16128207
28.

Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses.

Karrer U, Wagner M, Sierro S, Oxenius A, Hengel H, Dumrese T, Freigang S, Koszinowski UH, Phillips RE, Klenerman P.

J Virol. 2004 Mar;78(5):2255-64.

29.

Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P.

J Immunol. 2003 Feb 15;170(4):2022-9.

30.

Marginal zone macrophages and immune responses against viruses.

Oehen S, Odermatt B, Karrer U, Hengartner H, Zinkernagel R, López-Macías C.

J Immunol. 2002 Aug 1;169(3):1453-8.

31.

Viral escape mechanisms--escapology taught by viruses.

Lucas M, Karrer U, Lucas A, Klenerman P.

Int J Exp Pathol. 2001 Oct;82(5):269-86. Review.

32.

Memory T cells: total recall or just a sense of déjà vu?

Karrer U, Oxenius A, Phillips R, Klenerman P.

Nat Immunol. 2001 Nov;2(11):991-3. No abstract available.

PMID:
11685219
33.

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.

Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H, Zinkernagel RM.

Nature. 2001 Jun 28;411(6841):1058-64. Erratum in: Nature 2001 Sep 13;413(6852):183.

PMID:
11429607
34.

Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect.

Karrer U, Althage A, Odermatt B, Hengartner H, Zinkernagel RM.

Eur J Immunol. 2000 Oct;30(10):2799-807.

35.

Antiviral B cell memory in the absence of mature follicular dendritic cell networks and classical germinal centers in TNFR1-/- mice.

Karrer U, López-Macías C, Oxenius A, Odermatt B, Bachmann MF, Kalinke U, Bluethmann H, Hengartner H, Zinkernagel RM.

J Immunol. 2000 Jan 15;164(2):768-78.

36.

A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria.

Ochsenbein AF, Karrer U, Klenerman P, Althage A, Ciurea A, Shen H, Miller JF, Whitton JL, Hengartner H, Zinkernagel RM.

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9293-8.

37.

Immune surveillance against a solid tumor fails because of immunological ignorance.

Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, Zinkernagel RM.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2233-8.

38.

IL-12 is not required for induction of type 1 cytokine responses in viral infections.

Oxenius A, Karrer U, Zinkernagel RM, Hengartner H.

J Immunol. 1999 Jan 15;162(2):965-73.

39.

Dendritic cells efficiently induce protective antiviral immunity.

Ludewig B, Ehl S, Karrer U, Odermatt B, Hengartner H, Zinkernagel RM.

J Virol. 1998 May;72(5):3812-8.

40.

On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice.

Karrer U, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, Miyawaki S, Hengartner H, Zinkernagel RM.

J Exp Med. 1997 Jun 16;185(12):2157-70.

41.

Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice.

Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B.

Int Immunol. 1996 Jan;8(1):23-36.

PMID:
8671586
42.

Glycosylation of acute phase proteins and interleukins following hip arthroplasty. Inflammation parameters studied in 10 patients.

Fassbender K, Gerber B, Karrer U, Sobieska M, Aeschlimann A, Müller W.

Acta Orthop Scand. 1993 Apr;64(2):216-20.

PMID:
7684552
43.

[Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction?].

Karrer U, Aeschlimann A, Fassbender K, Vogt P, Müller W.

Schweiz Med Wochenschr. 1992 Feb 15;122(7):233-6. German.

PMID:
1539125

Supplemental Content

Loading ...
Support Center